Angled 60 degree blades 5.5 mm.
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size.
The rectangular large-field lens of the 2631 are ideal for reading and writing.
Medicine Products:(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3...e of every three children is chronically malnouris...ing the poorest country in the Western Hemisphere....len bellies, orange hair, listlessness and dull ey...e clinical professor of pediatrics at Washington U...
...ied people stole an eye from a dead body kept at B...tisgarh, police said Saturday.// The incident tha...ilai, 30 km west from here. The deceased, 32-year-...tted to the hospital last week after he met with a...
... to the researchers at the McMaster University inc...t still remains controversial.// Sports drink pla...ains carbohydrates and sodium. Carbohydrates provi...maintains fluid balance in the body. The study, wh...
... been a storm brewing over a particular brand of m...eople who are on the warfarin drug. Fonterra, the ...and yogurt, has said that they were well aware of ...ng the blood-thinning drug. Yet Fonterra decided n...
Other Medicine News:Health News:Crusade Against Malnutrition 2Health News:Crusade Against Malnutrition 3Health News:Is Addition Of Proteins In The Sports Drink Beneficial? 2(Date:8/18/2008)... - Clinical trial currently in Phase I -,...re/ -- Tobira,Therapeutics Inc., a clinical stage ...d product discovery against life-threatening and l...the issuance of Patent No. 7,371,772,B2 by the U.S... TBR-652, a,CCR5 antagonist currently in Phase I d...
(Date:8/14/2008)... A Complimentary Continuing Education Activi...egalovirus (CMV) is a,significant cause of morbidi...em cell transplantation. The clinical manifestatio...ointestinal disease to life-threatening,pneumonia,...In order to prevent CMV infection and reduce CMV d...
(Date:8/14/2008)... Phase 2 development to begin in late 2008 or in e...ire-FirstCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) to...roof-of-concept trial of NU172, demonstrating that...d maintained anticoagulation with a rapid,return t...orable safety,profile., "NU172 has the potential ...
(Date:8/13/2008)...lidates QTinno(TM) - proves the ability to automat...n challenging samples, SANTA CLARA, Calif., Aug. ... Bulletin Board: NWCI) a cardiac diagnostic and se...third external validation study of QTinno(TM),(the...t industry leading,cardiac safety expert with exte...
Breaking Medicine Technology:CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 1Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 2Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 3Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 4Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 5Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 6Escalon 28R 29 Reports Financial Results for 2007 Fiscal Year 2401 7Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2 28TM 29 Treatment System for Fibroadenomas 2397 1Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2 28TM 29 Treatment System for Fibroadenomas 2397 2CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path 2394 1CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path 2394 2Community Leaders to Host Press Event at L A Central Jail Urging Governor to Sign AB 1334 2390 1Community Leaders to Host Press Event at L A Central Jail Urging Governor to Sign AB 1334 2390 2...rial in non-small cell lung cancer -, LOS ANGELES,...Genetics, Inc. today announced that positive Phase...f the Journal of Clinical,Oncology suggests that l...ss-Complementing 1 (ERCC-1) in patient biopsies,wi...dicts for,sensitivity to cisplatin-based chemother...
...ul 9, 2007 - TransPharma Medical,Ltd., a specialty...,and commercialization of drug products utilizing ...hnology, announced today,promising results of its ...nd pharmacokinetic profile of its ViaDerm-hPTH (1-...seven day, repeated dose application, parallel gro...
Other Medicine Technology:Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3